Creative Biolabs announced an upcoming webinar on August 22, 2025, focusing on the tumoroid-on-a-chip platform, a microfluidic-based 3D tumor model designed to enhance preclinical testing accuracy. The webinar, presented by Dr. Mohsen Akbari from the University of Victoria, aims to explore the potential of this technology in revolutionizing cancer research and drug development.
The tumoroid-on-a-chip platform represents a significant advancement over traditional 2D cultures by incorporating key structural and cellular features of solid tumors, thereby providing a more physiologically relevant environment for testing. This innovation is particularly crucial for immunotherapy screening and early-stage drug development, where the need for precise and reliable cancer models is paramount.
Key topics of the webinar include the evolution of tumor chips, strategies for incorporating cellular heterogeneity, and the application of these systems in preclinical drug testing and personalized oncology. Dr. Akbari, a renowned expert in microengineering and biomaterials, will share insights from his extensive research, which has been widely recognized in the scientific community.
Creative Biolabs, known for its comprehensive portfolio of 3D tumor modeling platforms, continues to support oncology research by offering advanced tools for evaluating drug responses under conditions that closely mimic the in vivo tumor microenvironment. This webinar is an invaluable opportunity for researchers and professionals in oncology and related fields to learn about the latest advancements in cancer research technology.
